ClinicalTrials.Veeva

Menu

Wholegrain Cereal Diet and Insulin Sensitivity

F

Federico II University

Status

Completed

Conditions

Metabolic Syndrome

Treatments

Other: Refined cereal diet
Other: Wholegrain cereal diet

Study type

Interventional

Funder types

Other

Identifiers

NCT00945854
European Community
04022009

Details and patient eligibility

About

A diet with the multiple beneficial characteristics of whole grains and, more in general, of "healthy cereals" favorably influences glucose and insulin metabolism in subjects with metabolic syndrome. Therefore, the aim of the study is to evaluate the long term effects of a diet containing "healthy cereals" versus a control diet, on glucose and insulin metabolism in subjects with metabolic syndrome.

Enrollment

60 patients

Sex

All

Ages

40 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects with at least three of the following criteria of metabolic syndrome according to ATPIII-NCEP criteria:

    1. waist circumference >102 for men and 88 for women,
    2. fasting total serum triacyglycerol concentration >1.7 mmol/L,
    3. fasting HDL cholesterol <1.0 mmol/L for men or <1.3 mmol/L for women,
    4. IFG (plasma glucose between 6.1 and 6.9 mmol/L) or
    5. blood pressure >130/85 mmHg or use of blood pressure medication
  • Hypertension in stable control (BP <135/80 mmHg) by means of drugs, which will not be allowed to be changed during the study

  • Absence of main cardiovascular events (IMA, Ictus)

Exclusion criteria

  • Diabetes mellitus diagnosed according to history of diabetes or blood glucose ≥ 200 mg/dL (11.1 mmol/L) 2 hours after a 75 g Oral glucose tolerance test (OGTT) to be performed during the run-in period in all the subjects
  • Any drug able to influence glucose and lipid metabolism (hypolipidemic drugs, cholesterol lowering foodstuffs, anti-inflammatory drugs)
  • Renal failure (serum creatinine > 1.5 mg/dL) and liver failure (ALT/AST> 2 times above normal values)
  • Anemia (Hb < 12g/dl) or any other chronic disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Wholegrain cereal diet
Active Comparator group
Description:
Treatment with a diet based on wholegrain cereals and foods with low glycemic index
Treatment:
Other: Wholegrain cereal diet
Refined cereal diet
Active Comparator group
Description:
Treatment with a diet based on refined cereals and foods with high glycemic index
Treatment:
Other: Refined cereal diet

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems